Cited by 29

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Disruptive chemicals, senescence and immortality

Carnero, Amancio, Blanco-Aparicio, Carmen, Kondoh, Hiroshi, Lleonart, Matilde E., Martinez-Leal, Juan Fernando, Mondello, Chiara, Scovassi, A.Ivana, Bisson, William H., Amedei, Amedeo, Roy, Rabindra, Woodrick, Jordan, Colacci, Annamaria, Vaccari, Monica, Raju, Jayadev, Al-Mulla, Fahd, Al-Temaimi, Rabeah, Salem, Hosni K., Memeo, Lorenzo, Forte, Stefano, Singh, Neetu, Hamid, Roslida A., Ryan, Elizabeth P., Brown, Dustin G., Wise, John Pierce, Wise, Sandra S., Yasaei, Hemad·2015·Carcinogenesis

DOI 10.1093/carcin/bgv029

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/carcin/bgv029

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Telomere Shortening Triggers Senescence of Human Cells through a Pathway Involving ATM, p53, and p21CIP1, but Not p16INK4a
Herbig, U., Jobling, W. A., Chen, B. P. C., Chen, D. J., & Sedivy, J. M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00256-4 · Cited by 1,344
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Living on a break: cellular senescence as a DNA-damage response
d'Adda di Fagagna, F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2440 · Cited by 1,170
The FoxO code
Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046
p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis
Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Cellular mechanisms of tumour suppression by the retinoblastoma gene
Burkhart, D. L., & Sage, J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2399 · Cited by 974
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843
Telomeres and telomerase in cancer
Artandi, S. E., & DePinho, R. A. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp268 · Cited by 823
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1375 · Cited by 649
Self-citation
Glycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Self-citation
A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., et al. (2013) · Nature · doi:10.1038/nature12154 · Cited by 633
Telomeres and telomerase
Chan, S. R. W. L., & Blackburn, E. H. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1370 · Cited by 595
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568
Replicative Senescence: Implications for in Vivo Aging and Tumor Suppression
Smith, J. R., & Pereira-Smith, O. M. (1996) · Science · doi:10.1126/science.273.5271.63 · Cited by 547
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Dörr, J. R., Yu, Y., Milanovic, M., Beuster, G., Zasada, C., Däbritz, J. H. M., Lisec, J., Lenze, D., Gerhardt, A., Schleicher, K., et al. (2013) · Nature · doi:10.1038/nature12437 · Cited by 541
Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry
Sage, J., Miller, A. L., Pérez-Mancera, P. A., Wysocki, J. M., & Jacks, T. (2003) · Nature · doi:10.1038/nature01764 · Cited by 538
Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence
Guerra, C., Collado, M., Navas, C., Schuhmacher, A. J., Hernández-Porras, I., Cañamero, M., Rodriguez-Justo, M., Serrano, M., & Barbacid, M. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.05.011 · Cited by 516
Hallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502
Senescent Human Fibroblasts Increase the Early Growth of Xenograft Tumors via Matrix Metalloproteinase Secretion
Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
Agents that cause DNA double strand breaks lead to p16INK4a enrichment and the premature senescence of normal fibroblasts
Robles, S. J., & Adami, G. R. (1998) · Oncogene · doi:10.1038/sj.onc.1201862 · Cited by 498
Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene
Newbold, R. F., & Overell, R. W. (1983) · Nature · doi:10.1038/304648a0 · Cited by 436
The power and the promise of oncogene-induced senescence markers
Collado, M., & Serrano, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1884 · Cited by 404
Many roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397
A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40535 · Cited by 374
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
Cellular senescence: putting the paradoxes in perspective
Campisi, J. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.005 · Cited by 368
In situ analyses of genome instability in breast cancer
Chin, K., de Solorzano, C. O., Knowles, D., Jones, A., Chou, W., Rodriguez, E. G., Kuo, W.-L., Ljung, B.-M., Chew, K., Myambo, K., et al. (2004) · Nature Genetics · doi:10.1038/ng1409 · Cited by 361
The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence
de Jesus, B. B., Schneeberger, K., Vera, E., Tejera, A., Harley, C. B., & Blasco, M. A. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00700.x · Cited by 348
Mechanisms of cellular senescence in human and mouse cells.
Itahana, K., Campisi, J., & Dimri, G. P. (2004) · Biogerontology · doi:10.1023/b:bgen.0000017682.96395.10 · Cited by 338
Effects of Reverse Transcriptase Inhibitors on Telomere Length and Telomerase Activity in Two Immortalized Human Cell Lines
Strahl, C., & Blackburn, E. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.1.53 · Cited by 335
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Coppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302
Extracellular superoxide dismutase is a major antioxidant in human fibroblasts and slows telomere shortening
Serra, V., von Zglinicki, T., Lorenz, M., & Saretzki, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207939200 · Cited by 278
The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
Korotchkina, L. G., Leontieva, O. V., Bukreeva, E. I., Demidenko, Z. N., Gudkov, A. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100160 · Cited by 278
Oncogene-Induced Senescence: Putting the Brakes on Tumor Development
Braig, M., & Schmitt, C. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4006 · Cited by 274
Cellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254
Quantitative assessment of markers for cell senescence
Lawless, C., Wang, C., Jurk, D., Merz, A., Zglinicki, T. V., & Passos, J. F. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.01.018 · Cited by 240
Links between mutant p53 and genomic instability
Hanel, W., & Moll, U. M. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23400 · Cited by 216
Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
Pantoja, C., & Serrano, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202880 · Cited by 201
Molecular signature of oncogenic ras-induced senescence
Mason, D. X., Jackson, T. J., & Lin, A. W. (2004) · Oncogene · doi:10.1038/sj.onc.1208172 · Cited by 127
All Roads Lead to mTOR: Integrating Inflammation and Tumor Angiogenesis
Lee, D.-F., & Hung, M.-C. (2007) · Cell Cycle · doi:10.4161/cc.6.24.5085 · Cited by 115
TOR-Driven Aging: Speeding Car Without Brakes
Blagosklonny, M. V. (2009) · Cell Cycle · doi:10.4161/cc.8.24.10310 · Cited by 95
The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence
Haferkamp, S., Tran, S. L., Becker, T. M., Scurr, L. L., Kefford, R. F., & Rizos, H. (2009) · Aging · doi:10.18632/aging.100051 · Cited by 77
Markers of cellular senescence.
Carnero, A. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_4 · Cited by 68
Self-citation
Cell senescence as both a dynamic and a static phenotype
Young, A. R. J., Narita, M., & Narita, M. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_1 · Cited by 50
Involvement of RB gene family in tumor angiogenesis
Gabellini, C., Del Bufalo, D., & Zupi, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209631 · Cited by 47
Executing cell senescence
Narita, M., & Lowe, S. W. (2004) · Cell Cycle · doi:10.4161/cc.3.3.699 · Cited by 29
Mitochondrial dysfunction and cell senescence — skin deep into mammalian aging
Passos, J. F., & von Zglinicki, T. (2012) · Aging · doi:10.18632/aging.100432 · Cited by 28

Research works printed but not linked: 276

10.1038/299633a0 · DOI
10.1016/0014-4827(65)90211-9 · DOI · Paper page
10.1016/S0092-8674(00)81683-9 · DOI · Paper page
Untergasser, 2002, Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer, Cancer Res, 62, 6255
10.1593/neo.05250 · DOI
10.1371/journal.pone.0003230 · DOI
Correia-Melo, 2013, Robust multiparametric assessment of cellular senescence, Methods Mol. Biol, 965, 409, 10.1007/978-1-62703-239-1_27 · DOI
10.1016/j.lfs.2008.07.015 · DOI
10.1111/j.1469-185X.2010.00154.x · DOI
10.1016/0022-5193(73)90198-7 · DOI
10.1016/S0962-8924(00)89044-3 · DOI
Kipling, 1999, Telomere-dependent senescence, Nat. Biotechnol, 17, 313, 10.1038/7827 · DOI
Carnero, 2003, Cellular senescence and cancer, Res. Adv. Cancer, 3, 183
Chandeck, 2010, Oncogene-induced cellular senescence, Adv. Anat. Pathol, 17, 42, 10.1097/PAP.0b013e3181c66f4e · DOI
10.4161/cc.10.16.16422 · DOI
10.1038/sj.onc.1210881 · DOI · Paper page
10.1016/j.mad.2008.03.009 · DOI
10.1093/nar/gkm1064 · DOI
Wei, 1999, Expression of catalytically active telomerase does not prevent premature senescence caused by overexpression of oncogenic Ha-Ras in normal human fibroblasts, Cancer Res, 59, 1539
10.1016/S1535-6108(02)00159-9 · DOI
10.1101/gad.8.21.2540 · DOI · Paper page
10.1016/S0955-0674(00)00278-7 · DOI · Paper page
10.1172/JCI200420761 · DOI
10.1016/j.cell.2013.10.041 · DOI · Paper page
10.1073/pnas.95.25.14723 · DOI · Paper page
10.1038/22780 · DOI · Paper page
10.1101/gad.12.12.1769 · DOI
10.1158/0008-5472.CAN-03-4030 · DOI · Paper page
10.1007/s12094-010-0528-2 · DOI
Malumbres, 2003, Cell cycle deregulation: a common motif in cancer, Prog. Cell Cycle Res, 5, 5
10.1038/sj.onc.1210704 · DOI
10.1371/journal.pone.0009305 · DOI
10.1038/sj.onc.1202261 · DOI
10.1006/excr.1993.1095 · DOI
10.1101/SQB.1994.059.01.046 · DOI
10.4061/2011/205378 · DOI
Carnero, 2010, Epigenetic mechanisms in senescence, immortalisation and cancer, Biol. Rev. Camb. Philos. Soc
10.1128/MCB.22.10.3497-3508.2002 · DOI · Paper page
10.4161/cc.7.21.6919 · DOI
10.4161/cc.9.4.10766 · DOI
10.1093/carcin/bgm246 · DOI
10.1101/gad.12.19.3008 · DOI · Paper page
10.1073/pnas.091100298 · DOI
10.1038/35018127 · DOI
10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I · DOI
Bond, 1996, Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence, Oncogene, 13, 2097
10.1038/sj.onc.1201880 · DOI
10.1038/35004020 · DOI
10.1126/science.277.5327.831 · DOI · Paper page
10.1038/sj.onc.1207839 · DOI
10.1128/MCB.25.17.7423-7431.2005 · DOI
Serrano, 2003, Proliferation: the cell cycle, Adv. Exp. Med. Biol, 532, 13, 10.1007/978-1-4615-0081-0_2 · DOI
10.1073/pnas.190343497 · DOI
Jarrard, 1999, p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells, Cancer Res, 59, 2957
10.1128/MCB.01592-06 · DOI
10.1016/S0168-9525(98)01470-X · DOI
Carnero, 1998, The INK4 family of CDK inhibitors, Curr. Top. Microbiol. Immunol, 227, 43
10.1038/sj.onc.1201212 · DOI
10.1101/SQB.1994.059.01.008 · DOI
10.1038/onc.2012.45 · DOI · Paper page
10.1038/nrc1991 · DOI
10.1038/sj.onc.1208735 · DOI
10.1073/pnas.141235398 · DOI
10.1002/mc.20422 · DOI
10.1093/carcin/bgm246 · DOI
10.2174/138161210789941865 · DOI
10.1093/carcin/bgm052 · DOI
Lacal, 1994, Regulation of ras proteins and their involvement in signal-transduction pathways (review), Oncol. Rep, 1, 677
10.1038/sj.onc.1205181 · DOI
10.1016/j.molcel.2010.09.026 · DOI
10.1074/jbc.M000759200 · DOI
10.1016/S0531-5565(02)00133-X · DOI
10.1038/84879 · DOI
10.1038/nature04809 · DOI
10.2174/156652409788488766 · DOI · Paper page
10.1158/0008-5472.CAN-08-1539 · DOI · Paper page
10.2174/156800910791054158 · DOI
10.1111/j.1748-1716.2007.01780.x · DOI
10.4049/jimmunol.176.5.2711 · DOI
10.1093/gerona/60.1.4 · DOI
10.1042/bst0320360 · DOI
10.1016/j.cell.2006.01.016 · DOI · Paper page
10.4161/cc.7.21.6965 · DOI · Paper page
10.2353/ajpath.2010.091050 · DOI
10.1016/j.gene.2007.10.022 · DOI
10.1093/carcin/15.1.11 · DOI
10.1016/0304-3835(96)04218-8 · DOI
10.1038/283596a0 · DOI · Paper page
10.1073/pnas.82.8.2394 · DOI
10.1093/carcin/14.5.833 · DOI
10.1186/bcr1275 · DOI · Paper page
10.1177/10454411010120010301 · DOI
10.1016/S0168-1702(02)00190-9 · DOI
10.1093/carcin/16.2.193 · DOI
10.1016/0304-3835(89)90060-8 · DOI
10.1080/01635589609514482 · DOI
10.1016/S0887-2333(00)00006-0 · DOI
10.1016/j.taap.2009.01.009 · DOI
10.1039/b903049b · DOI
10.3109/10408440903401511 · DOI
10.1016/S1734-1140(11)70707-1 · DOI · Paper page
10.3727/096368908786991542 · DOI · Paper page
10.1016/j.jhep.2005.05.036 · DOI · Paper page
10.1016/j.bbrc.2005.07.014 · DOI · Paper page
Lee, 2012, Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway, Int. J. Mol. Med, 29, 883
10.1016/j.toxlet.2011.01.015 · DOI
10.1016/j.mrgentox.2007.08.006 · DOI
10.1016/S0890-6238(02)00005-9 · DOI
10.1080/009841097160573 · DOI
Takahashi, 2004, Bisphenol A from dental polycarbonate crown upregulates the expression of hTERT, J. Biomed. Mater. Res. B. Appl. Biomater, 71, 214, 10.1002/jbm.b.30085 · DOI
10.1038/25870 · DOI
10.4049/jimmunol.181.10.7400 · DOI
10.1089/rej.2010.1085 · DOI
Jacob, 2009, The effect of cotinine on telomerase activity in human vascular smooth muscle cells, J. Cardiovasc. Surg. (Torino), 50, 345
10.1093/carcin/bgm148 · DOI
10.1158/0008-5472.CAN-05-2494 · DOI
10.1097/FJC.0b013e31802ef519 · DOI
10.1038/sj.onc.1210886 · DOI
10.1038/bjp.2008.272 · DOI
10.1038/nature05354 · DOI · Paper page
10.1016/j.cell.2011.02.013 · DOI · Paper page
10.1097/COC.0b013e3181b0c4c2 · DOI
Sun, 2003, Effects of allicin on both telomerase activity and apoptosis in gastric cancer SGC-7901 cells, World J. Gastroenterol, 9, 1930, 10.3748/wjg.v9.i9.1930 · DOI
10.1016/S0304-3835(02)00192-1 · DOI
10.1097/01.ju.0000121329.37206.1b · DOI
10.1371/journal.pone.0011457 · DOI
10.1358/dnp.2000.13.7.671717 · DOI
10.1016/j.canlet.2004.11.045 · DOI
10.2174/138955712802762220 · DOI
Ambs, 1999, Cancer-prone oxyradical overload disease, IARC Sci. Publ, 295
10.3109/10715762.2011.571685 · DOI
10.1007/s00726-010-0600-9 · DOI · Paper page
Alfonso, 2009, Does aspirin acetylate multiple cellular proteins? (Review), Mol. Med. Rep, 2, 533
10.1179/135100001101536085 · DOI
Maehle, 1992, Altered p53 gene structure and expression in human epithelial cells after exposure to nickel, Cancer Res, 52, 218
10.1016/j.freeradbiomed.2011.04.008 · DOI
10.1016/j.mrrev.2007.11.008 · DOI
10.1023/B:MCBI.0000007262.26044.e8 · DOI · Paper page
10.1006/taap.2001.9157 · DOI
10.1016/S0898-6568(01)00175-9 · DOI · Paper page
10.2174/1568009053202072 · DOI
10.1016/j.niox.2010.06.001 · DOI
Davis, 2000, Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon, J. Nutr, 130, 2903, 10.1093/jn/130.12.2903 · DOI
10.1016/j.semcancer.2006.10.009 · DOI · Paper page
10.1038/nature01960 · DOI · Paper page
10.1177/0960327112440113 · DOI
10.1517/13543770902762893 · DOI · Paper page
10.1016/j.abb.2009.01.018 · DOI · Paper page
Duntas, 2011, Resveratrol and its impact on aging and thyroid function, J. Endocrinol. Invest, 34, 788
10.4161/cc.7.8.5740 · DOI
Maclaine, 2009, The regulation of p53 by phosphorylation: a model for how distinct signals integrate into the p53 pathway, Aging (Albany. NY), 1, 490, 10.18632/aging.100047 · DOI
10.1016/S0960-9822(99)80486-2 · DOI · Paper page
10.1258/ebm.2011.011107 · DOI
10.1007/s40265-013-0034-2 · DOI
10.1517/13543784.2012.726218 · DOI
10.1586/era.12.43 · DOI
10.1002/j.1875-9114.2012.01084.x · DOI
10.7150/ijbs.4499 · DOI
10.1016/j.niox.2010.06.005 · DOI
Wang, 2012, Akt signaling-associated metabolic effects of dietary gold nanoparticles in Drosophila, Sci. Rep, 2, 563, 10.1038/srep00563 · DOI
Jang, 2012, Silver nanoparticles modify VEGF signaling pathway and mucus hypersecretion in allergic airway inflammation, Int. J. Nanomed, 7, 1329
10.1016/j.colsurfb.2009.04.025 · DOI
10.1016/j.toxlet.2011.09.002 · DOI
10.1016/j.toxlet.2010.12.010 · DOI
10.2174/138945011798184155 · DOI
10.1002/ijc.24398 · DOI
10.1093/geronj/11.3.298 · DOI · Paper page
Vergel, 2010, Cellular senescence as a target in cancer control, J. Aging Res, 2011, 725365
10.1186/1476-4598-8-3 · DOI
10.1016/S0047-6374(02)00091-X · DOI
10.1016/S0092-8674(00)81902-9 · DOI · Paper page
10.1128/MCB.23.1.389-401.2003 · DOI · Paper page
10.1038/534 · DOI
10.1126/science.8108730 · DOI
10.1074/jbc.274.12.7936 · DOI · Paper page
10.1093/pcp/pch110 · DOI
10.1126/science.1064653 · DOI
10.1046/j.1474-9728.2003.00065.x · DOI
10.1016/0891-5849(95)02111-6 · DOI · Paper page
10.1006/abbi.1996.0189 · DOI
10.1038/sj.onc.1202707 · DOI
Kondoh, 2007, Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization, Histol. Histopathol, 22, 85
10.1016/j.ccr.2012.09.020 · DOI
10.1007/BF01877355 · DOI
Virchow, 1863, Aetiologie der neoplastischen Geshwültse/Pathogenie der neoplastishchen Geshwülste, Die Krankhaften Geschwülste, 57
10.1093/carcin/bgp127 · DOI
10.1016/j.ccr.2005.02.013 · DOI · Paper page
10.1023/B:APPT.0000018794.26438.22 · DOI
10.1016/S0092-8674(00)81988-1 · DOI
10.1016/j.semcancer.2004.06.006 · DOI · Paper page
10.1016/j.ccr.2007.01.012 · DOI · Paper page
10.1053/j.gastro.2011.05.041 · DOI
Narlik-Grassow, (2014) Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia, PLoS One, 8
10.1038/nature05529 · DOI · Paper page
10.1146/annurev-pathol-121808-102144 · DOI · Paper page
10.1073/pnas.211053698 · DOI · Paper page
10.1016/j.mad.2012.09.004 · DOI · Paper page
10.1186/1756-8722-5-13 · DOI · Paper page
Chen, 2000, Replicative senescence and oxidant-induced premature senescence. Beyond the control of cell cycle checkpoints, Ann. N. Y. Acad. Sci, 908, 111, 10.1111/j.1749-6632.2000.tb06640.x · DOI
Chang, 1999, A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents, Cancer Res, 59, 3761

200 of 276 shown

Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges
Chalak, M., Hesaraki, M., Mirbahari, S. N., Yeganeh, M., Abdi, S., Rajabi, S., & Hemmatzadeh, F. (2024) · Life · doi:10.3390/life14030417 · Cited by 66

See all 29

Authors: Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., Woodrick, J., Colacci, A., Vaccari, M., Raju, J., Al-Mulla, F., Al-Temaimi, R., Salem, H. K., Memeo, L., Forte, S., Singh, N., Hamid, R. A., Ryan, E. P., Brown, D. G., Wise, J. P., Wise, S. S., & Yasaei, H.
Venue: Carcinogenesis
Publisher: Oxford University Press (OUP)
Published: 2015-06
Volume: 36
Issue: Suppl 1
Pages: S19-S37
ISSN: 0143-3334
1460-2180
DOI: 10.1093/carcin/bgv029
Cited by: 29
References: 64
Language: en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Disruptive chemicals, senescence and immortality

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks